EEA1 and amyloidosis: In conclusion, we observed enlarged EEA1 positive puncta volume, a hallmark of endosomal alterations, in AD patients, particularly at the dementia stage of the disease, that tend to correlate with amyloid load and cognition, therefore showing potential as biomarkers for AD.